期刊
COORDINATION CHEMISTRY REVIEWS
卷 460, 期 -, 页码 -出版社
ELSEVIER SCIENCE SA
DOI: 10.1016/j.ccr.2022.214462
关键词
Homonuclear; Heteronuclear Ru(II)/Ir(III)/Re(I); Target specificity; Cancer therapy
资金
- Department of Science and Technology, Government of India [CRG/2021/002267]
- VIT University
This review article discusses the research on the cellular uptake, localization, mechanism of action, and cytotoxicity profiles of ruthenium, iridium, and rhenium-based complexes as potential target-specific chemotherapeutic agents.
More than 10 million death tolls in 2020 were reported as a result of heinous impact of cancer, making it second most prime cause of death after cardiovascular diseases. In annihilation of cancer, many platinum-based drugs are currently being applied in anticancer therapy but the therapeutic value of these complexes comes with severe side effects. Hence, a profound research is needed to develop more selective and target specific chemotherapeutics so as to diminish the side effects. In this scenario, the anticancer activity of ruthenium, iridium and rhenium-based complexes have shown a light of hope for being explored as anticancer metallotherapeutics. This present review article, therefore, delineates the study of cellular uptake, localisation, mechanism of action and cytotoxicity profiles of several mononuclear and multinuclear ruthenium, iridium and rhenium complexes as target specific potential chemotherapeutic agents. (C) 2022 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据